The biotech sector recently saw a flurry of activity involving Jacobs Solutions Inc. (NYSE: J) stock. Multiple investment firms including Marco Investment Management LLC, Lisanti Capital Growth LLC, and Wealth Advisory Solutions LLC, among others, have significantly increased their holdings, with the latter two investing over $900,000 and $300,000 respectively.
Conversely, a number of firms such as Mutual of America Capital Management LLC and Washington Trust Advisors Inc. have reduced their shares significantly. Despite such sales, the majority of shares (87%) belong to institutional owners. Over the short term, the stock has experienced a dip, losing 6% since its last earnings report, causing short interest to increase.
However, analysts project a stock target price of $155.89, suggesting potential for rebound. Recently, Jacobs secured a $13.4M cybersecurity deal which is anticipated to boost growth. Furthermore, they unveiled a $1.5 billion stock buyback plan, signaling optimism about the company’s future.
Within the billionaire investor community, Jacobs Solutions stock has gained favor, particularly with George Soros, boosting investor interest. Lastly, Jacobs has announced an increase in its dividend to $0.32 and about to spin-off its 'Critical Mission Solutions' and 'Cyber & Intelligence Government Services' businesses, adding to investor’s anticipation.
Jacobs Solutions Stocks News Analytics from Sat, 24 Aug 2024 07:00:00 GMT to Sat, 08 Mar 2025 11:58:53 GMT - Rating 2 - Innovation 2 - Information 9 - Rumor -2
